• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Tissue-type plasminogen activator in patients with lupus nephritis].

作者信息

Poliantseva L G, Bobkova I N, Tareeva I E, Podorol'skaia L V, Andreenko G V

出版信息

Ter Arkh. 1995;67(5):17-9.

PMID:7638768
Abstract

ELISA was used to measure tissue plasminogen activator antigen in blood plasma and urine of 42 patients with active lupus nephritis (16 with isolated urinary syndrome, 13 with nephrotic syndrome, 13 with rapidly progressive LN). Control groups consisted of 17 patients with inactive LN and 15 healthy subjects. Inhibition of fibrinolysis in vascular system correlating with the disease severity was found in patients with active LN. This may result from both defective synthesis of tissue plasminogen activator and neutralizing action of antiactivator. Urinary fibrinolytic activity was inhibited only in patients with rapidly progressive LN because of hyperactive synthesis of antiactivator. The above changes occur as endothelial cell dysfunction due to activating and damaging action of immune complexes, antibodies, cytokines on vascular endothelium. Zero activator activity of plasma and urine in patients with active LN reflects severe dysfunction of endothelial cell caused by its structural disorganization.

摘要

相似文献

1
[Tissue-type plasminogen activator in patients with lupus nephritis].
Ter Arkh. 1995;67(5):17-9.
2
[The functional activity of plasminogen activators in the blood plasma and urine of patients with lupus nephritis].[狼疮性肾炎患者血浆和尿液中纤溶酶原激活剂的功能活性]
Ter Arkh. 1994;66(6):39-41.
3
[The clinical importance of determining the von Willebrand factor in patients with lupus nephritis].[测定狼疮性肾炎患者血管性血友病因子的临床意义]
Ter Arkh. 1995;67(5):14-6.
4
[The venous occlusion test in assessing the fibrinolytic activity of the vascular endothelium in lupus nephritis patients].
Ter Arkh. 1995;67(4):42-5.
5
[Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].[尿内皮功能障碍标志物及血管生成因子检测在慢性肾小球肾炎肾小管间质纤维化评估中的临床意义]
Ter Arkh. 2007;79(6):10-5.
6
[Urinary fibronectin as an indicator of kidney fibrosis in nephritis].[尿纤连蛋白作为肾炎肾纤维化的指标]
Ter Arkh. 1999;71(6):34-8.
7
[Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].[内皮功能障碍和血液流变学紊乱标志物对评估慢性肾小球肾炎活动度和预后的意义]
Ter Arkh. 2010;82(1):47-51.
8
Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.狼疮性肾炎肾功能转归的决定因素:一项单中心回顾性研究
QJM. 2008 Apr;101(4):313-6. doi: 10.1093/qjmed/hcn008. Epub 2008 Feb 12.
9
[Thrombocytopenia in patients with lupus nephritis].[狼疮性肾炎患者的血小板减少症]
Ter Arkh. 1995;67(5):9-13.
10
[Laboratory and morphologic parameters in patients with lupus nephritis].[狼疮性肾炎患者的实验室及形态学参数]
Srp Arh Celok Lek. 2002 Aug;130 Suppl 3:38-41.